Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
GPCR Desensitization01:12

GPCR Desensitization

6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mechanism of <i>Tongxie Yaofang</i> for reducing 5-HT-induced oxidative stress injury in BRL 3A cells: the mediating role of the SREBP-1/CD1 pathway].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2026
Same author

The relationship between sleep quality and physical learning engagement among Chinese college students: a variable centered and person centered analysis.

Frontiers in public health·2026
Same author

p300/Ahnak1 promotes the depression of I<sub>Ca,L</sub> of atrial myocytes induced by aging.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Piezo1 Knockdown Attenuates Hypertension-Induced Cardiac Fibrosis by Inhibiting Ca<sup>2+</sup>/β-Catenin Signalling Pathway.

Clinical and experimental pharmacology & physiology·2026
Same author

Baicalein links macrophage M2 polarization with reduced synovial inflammation to alleviate gouty arthritis.

Frontiers in immunology·2026
Same author

Targeting STIM1 attenuates LPS-induced cardiac dysfunction by reshaping calcium homeostasis and mitochondrial function.

Free radical biology & medicine·2026

Related Experiment Video

Updated: May 2, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

11.3K

PPARγ ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activity.

Fang Rao1, Ren-Qiang Yang2, Xiao-Shu Chen2

  • 1Department of Cardiology, Guangdong General Hospital, Guangzhou, PR China ; Guangdong Academy of Medical Sciences, Guangzhou, PR China.

Plos One
|March 4, 2014
PubMed
Summary
This summary is machine-generated.

Elevated hydrostatic pressure activates platelets, increasing aggregation and CD40L release. The peroxisome proliferator-activated receptor-γ (PPARγ) pathway is involved and can be modulated by Thiazolidinediones (TZDs).

More Related Videos

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.1K
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

21.5K

Related Experiment Videos

Last Updated: May 2, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

11.3K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.1K
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

21.5K

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Molecular Medicine

Background:

  • Hypertension is linked to platelet overactivity, but the direct impact of hydrostatic pressure on platelet function is not well understood.
  • Platelets play a crucial role in cardiovascular health and disease, with their activation implicated in thrombotic events.

Purpose of the Study:

  • To investigate the direct effects of elevated hydrostatic pressure on human platelet activation and function.
  • To explore the role of peroxisome proliferator-activated receptor-γ (PPARγ) in pressure-induced platelet activation.

Main Methods:

  • Primary human platelets were cultured in vitro under varying hydrostatic pressures (0, 120, 180, 240 mmHg).
  • Platelet aggregation, PAC-1 binding, CD40L translocation and release, and PPARγ activity were measured.
  • The effects of the PPARγ agonist Thiazolidinediones (TZDs) on pressure-induced platelet activation were assessed.

Main Results:

  • Elevated hydrostatic pressure induced morphological changes in platelets.
  • Increased platelet aggregation, PAC-1 binding, CD40L translocation, and soluble CD40L (sCD40L) release were observed at higher pressures (180 and 240 mmHg).
  • PPARγ activity increased with pressure, and TZDs attenuated pressure-induced platelet activation markers.

Conclusions:

  • Elevated hydrostatic pressure directly activates platelets, leading to increased aggregation and release of inflammatory mediators.
  • PPARγ plays a modulatory role in pressure-induced platelet activation.
  • Targeting the PPARγ pathway may offer a therapeutic strategy for managing hypertension-related platelet dysfunction.